Bio-Techne (TECH) Land & Improvements (2010 - 2016)
Bio-Techne (TECH) recorded quarterly Land & Improvements of $6.3 million in Q2 2016, down 14.93% quarter-over-quarter from $7.4 million in Q2 2015, and down 14.93% on a YoY basis from $7.4 million in Q3 2015.
Bio-Techne (TECH) Land & Improvements (2010 - 2016) Analysis & Trends
Bio-Techne's Land & Improvements history runs 7 years deep, the most recent figure standing at $6.3 million for Q2 2016.
- In Q2 2016, Land & Improvements fell 14.93% year-over-year to $6.3 million; the TTM figure through Jun 2016 stood at $6.3 million (down 14.93% YoY), while the FY2016 annual figure was $6.3 million, down 14.93% from the prior year.
- Land & Improvements was $6.3 million for Q2 2016 at Bio-Techne, down from $7.4 million in the prior quarter.
- In the past five years, Land & Improvements ranged from a high of $7.5 million in Q4 2012 to a low of $6.3 million in Q2 2016.
- Historically, Land & Improvements has averaged $7.4 million across 5 years, with a median of $7.4 million in 2013.
- The sharpest annual moves came in 2012 and 2016: Land & Improvements increased 0.67% in 2012, then fell 14.93% in 2016.
- A 5-year view of Land & Improvements shows it stood at $7.5 million in 2012, then retreated by 1.09% to $7.4 million in 2013, then dropped by 0.32% to $7.4 million in 2014, then slipped by 0.47% to $7.4 million in 2015, then dropped by 14.93% to $6.3 million in 2016.
- The last three Land & Improvements figures came in at $6.3 million (Q2 2016), $7.4 million (Q2 2015), and $7.4 million (Q3 2014), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 6.27 Mn |
| Jun 30, 2015 | 7.37 Mn |
| Sep 30, 2014 | 7.41 Mn |
| Jun 30, 2014 | 7.47 Mn |
| Mar 31, 2014 | 7.44 Mn |
| Dec 31, 2013 | 7.43 Mn |
| Sep 30, 2013 | 7.51 Mn |
| Jun 30, 2013 | 7.44 Mn |
| Mar 31, 2013 | 7.44 Mn |
| Dec 31, 2012 | 7.51 Mn |
| Sep 30, 2012 | 7.51 Mn |
| Jun 30, 2012 | 7.47 Mn |
| Mar 31, 2012 | 7.49 Mn |
| Dec 31, 2011 | 7.46 Mn |
| Sep 30, 2011 | 7.46 Mn |
| Jun 30, 2011 | 7.50 Mn |
| Jun 30, 2010 | 7.42 Mn |